Surmodics (NSDQ:SRDX) shares plummeted today despite third-quarter results that topped Wall Street projections.
Eden Prairie, Minn.-based Surmodics posted profits of $3.55 million, or 26¢ per share, on sales of $30.8 million for the three months ended Sept. 30, moving from red to black on revenue growth of 33.8% compared with Q3 2018.
Get the full story at our sister site, Drug Delivery Business News.
